A two-dose nasal spray may soon offer what has long seemed impossible: the ability to undo some of the mental decline that comes with growing older. Researchers at Texas A&M University say they have successfully reversed brain aging in laboratory studies, restoring memory and clearing the chronic inflammation that typically clouds thinking as we age.
The treatment works by delivering microscopic biological particles called extracellular vesicles directly into the brain through the nasal cavity. These vesicles carry microRNAs, molecules that act as master regulators of brain function, suppressing the inflammatory processes that damage neurons over time.
In tests, the therapy produced measurable improvements in just weeks. Animals treated with the nasal spray performed significantly better on memory tasks, more successfully identifying familiar objects and detecting changes in their environment. The effects persisted for months after the initial two doses, suggesting the treatment may trigger the brain's own repair systems.
Brain aging involves a process called neuroinflammaging, in which persistent low-level inflammation accumulates over decades. This chronic state interferes with memory and thinking ability and is considered a major driver of neurodegenerative diseases like dementia and Alzheimer's.
The Texas A&M team, led by Dr. Ashok Shetty, found that the nasal spray targets specific inflammatory pathways in the brain, particularly the NLRP3 inflammasome and cGAS-STING signaling systems. Beyond reducing inflammation, the treatment also restored activity in mitochondria, the cellular structures that generate energy. Aging and inflammation typically damage mitochondria, leaving brain cells less efficient. By reviving mitochondrial function, the therapy appeared to help neurons recover their ability to process and store information.
"We are giving neurons their spark back by reducing oxidative stress and reactivating the brain's mitochondria," said Dr. Madhu Leelavathi Narayana, a senior research scientist on the study.
One notable aspect of the findings is that the treatment produced similar results in both male and female test subjects, something researchers say is relatively uncommon in biomedical research.
The implications could reshape how society approaches aging. Dementia cases in the United States are projected to nearly double, rising from around 514,000 in 2020 to approximately 1 million by 2060. A simple nasal spray that could slow or reverse cognitive decline would represent a major breakthrough compared to current treatment options.
Shetty envisions a future where the therapy extends beyond dementia prevention. Stroke patients might use it to recover lost brain function, or older adults could take it routinely to maintain mental sharpness and engagement.
The research was funded by the National Institute on Aging, and the team has already filed a patent for the therapy. While human trials remain years away, the study demonstrates that brain aging may not be the irreversible process scientists long assumed it to be.
Author Jessica Williams: "If this nasal spray actually works in humans, it could rewrite everything we thought we knew about aging gracefully."
Comments